Cargando…
Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis
BACKGROUND: Systemic lupus erythematosus (SLE) is heterogeneous in organ involvement and disease severity, presenting a broad clinical phenotype. Systemic type I interferon (IFN) activity has been shown to be associated with lupus nephritis, autoantibodies, and disease activity in treated SLE patien...
Autores principales: | Miyachi, Kazusa, Iwamoto, Taro, Kojima, Shotaro, Ida, Tomoaki, Suzuki, Junya, Yamamoto, Takuya, Mimura, Norihiro, Sugiyama, Takahiro, Tanaka, Shigeru, Furuta, Shunsuke, Ikeda, Kei, Suzuki, Kotaro, Niewold, Timothy B., Nakajima, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936752/ https://www.ncbi.nlm.nih.gov/pubmed/36803843 http://dx.doi.org/10.1186/s13075-023-03010-0 |
Ejemplares similares
-
Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis
por: Kato, Manami, et al.
Publicado: (2021) -
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023) -
Implementation Status of Accrual Accounting System in Health Sector
por: Mehrolhassani, Mohammad Hossien, et al.
Publicado: (2015) -
High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus
por: Koelmeyer, Rachel, et al.
Publicado: (2020) -
Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2
por: Kageyama, Takahiro, et al.
Publicado: (2022)